These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6856049)

  • 41. Effects of short-term serotonin depletion on the efficacy of serotonin neurotransmission: electrophysiological studies in the rat central nervous system.
    Chaput Y; Lesieur P; de Montigny C
    Synapse; 1990; 6(4):328-37. PubMed ID: 1962911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers.
    de Montigny C; Chaput Y; Blier P
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():4-8. PubMed ID: 2175309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
    Lansdown MR; Nash HL; Preston PR; Wallis DI
    Br J Pharmacol; 1979 May; 66(1):80P-81P. PubMed ID: 454965
    [No Abstract]   [Full Text] [Related]  

  • 45. A serotonin agonist-antagonist reversible effect on Na+-K+-ATPase activity in the developing rat brain.
    Hernández RJ
    Dev Neurosci; 1982; 5(4):326-31. PubMed ID: 6291893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function.
    Pettibone DJ; Pflueger AB
    J Neurochem; 1984 Jul; 43(1):83-90. PubMed ID: 6726257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potentiation by quipazine of adrenergic transmission in mesenteric arteries of spontaneously hypertensive rats.
    Uruno T; Su C
    Eur J Pharmacol; 1984 May; 101(1-2):69-74. PubMed ID: 6086365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serotonergic agonists stimulate inositol lipid metabolism in rabbit platelets.
    Schächter M; Godfrey PP; Minchin MC; McClue SJ; Young MM
    Life Sci; 1985 Oct; 37(17):1641-7. PubMed ID: 2997568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circling produced by serotonin and dopamine agonists in raphe lesioned rats: a serotonin model.
    Slater P
    Pharmacol Biochem Behav; 1980 Dec; 13(6):817-21. PubMed ID: 7193875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antagonistic properties of quipazine at presynaptic serotonin receptors and alpha-adrenoceptors in rat brain cortex slices.
    Schlicker E; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):204-8. PubMed ID: 6275275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.
    Romero L; Bel N; Artigas F; de Montigny C; Blier P
    Neuropsychopharmacology; 1996 Oct; 15(4):349-60. PubMed ID: 8887989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat.
    Blier P; de Montigny C; Tardif D
    Psychopharmacology (Berl); 1984; 84(2):242-9. PubMed ID: 6438684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
    Gresch PJ; Strickland LV; Sanders-Bush E
    Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiological investigation of the adaptive response of the 5-HT system to the administration of 5-HT1A receptor agonists.
    Blier P; de Montigny C
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S42-8. PubMed ID: 1702486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Head twitches induced by LSD and quipazine: similarities and differences.
    Vetulani J; Bednarczyk B; Reichenberg K; Rokosz A
    Neuropharmacology; 1980 Feb; 19(2):155-8. PubMed ID: 6244515
    [No Abstract]   [Full Text] [Related]  

  • 56. Monoaminergic denervation of the rat hippocampus: microiontophoretic studies on pre- and postsynaptic supersensitivity to norepinephrine and serotonin.
    De Montigny C; Wang RY; Reader TA; Aghajanian GK
    Brain Res; 1980 Nov; 200(2):363-76. PubMed ID: 6968237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission.
    Haddjeri N; De Montigny C; Curet O; Blier P
    Eur J Pharmacol; 1998 Feb; 343(2-3):179-92. PubMed ID: 9570466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
    Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT
    De Gregorio D; Posa L; Ochoa-Sanchez R; McLaughlin R; Maione S; Comai S; Gobbi G
    Pharmacol Res; 2016 Nov; 113(Pt A):81-91. PubMed ID: 27544651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.